Origin and immunophenotype of aberrant IEL in RCDII patients

GJ Tack, RLJ van Wanrooij, Ton Langerak, JML Tjon, BME von Blomberg, DAM Heideman, J van Bergen, F Koning, G (Gerben) Bouma, CJJ Mulder, Marco Schreurs

Research output: Contribution to journalArticleAcademicpeer-review

50 Citations (Scopus)

Abstract

Objectives: Aberrant intra-epithelial lymphocytes (IELs) are the hallmark of refractory coeliac disease type II RCDII and considered a premalignant cell population from which aggressive enteropathy-associated T cell lymphoma (EATL) can evolve. The aim of this study was to gain further insight in the origin and characteristics of aberrant IELs by analysing T-cell receptor (TCR) rearrangements, and by immunophenotypic analysis of aberrant IELs. Design: Duodenal biopsies from 18 RCDII patients and three RCDII cell lines were analysed for the presence of TCR delta, gamma, and beta rearrangements. In addition, IELs isolated from biopsies derived from RCDII patients were phenotypically analysed. Results: Aberrant IELs showed an upregulated expression of granzyme B and decreased expression of PCNA. TCR rearrangements in the aberrant IEL population in biopsies of RCDII patients were heterogenic, which is most likely due to a variation in maturity. Similarly, RCDII cell lines displayed a heterogenic TCR rearrangement pattern. Conclusion: Aberrant IELs originate from deranged immature T lymphocytes and display clear differentiation to a cytotoxic phenotype. Aberrant IELs displayed different stages of maturity between RCDII patients, of which only the patients harbouring the most mature aberrant IEL population developed an EATL. (C) 2012 Elsevier Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)262-270
Number of pages9
JournalMolecular Immunology
Volume50
Issue number4
DOIs
Publication statusPublished - 2012

Research programs

  • EMC MM-02-72-03

Cite this